Ligand Pharmaceuticals, Inc. (LGND) Tops Q2 EPS by 10c; Boosts FY14 Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 313.14 -0.38 (0.12%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $313.52 | 52 Week High | $139.79 | |||
| Open | $319.00 | 52 Week Low | $82.07 | |||
| Day High | $319.99 | P/E | 728.23 | |||
| Day Low | $309.86 | EPS | $0.43 | |||
| Volume | 22,874 | |||||
